Hepatitis D Clinical Trials in Clichy
3 recruitingClichy, France
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Chronic Hepatitis D
Mirum Pharmaceuticals, Inc.120 enrolled22 locationsNCT07454837
Recruiting
Phase 3
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc.172 enrolled44 locationsNCT07200908
Recruiting
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
Hepatitis B, ChronicHepatitis D, Chronic
ANRS, Emerging Infectious Diseases800 enrolled38 locationsNCT04166266